Cell & Bioscience

Table 1 Clinicopathologic characteristics of patient samples in Cohorts 1 and 2

From: Overexpression of MACC1 and Its significance in human Breast Cancer Progression

Characteristic	Cohort 1		Cohort 2
	NO.	%	NO.	%
Total	245		185
Age
≤45	95	38.8	78	42.2
>45	150	61.2	107	57.8
Menopausal status
Premenopausal	116	53.2
Postmenopausal	102	46.8
Unknown	27
Clinical stage
I	81	33.1	21	11.4
II	91	37.1	80	43.2
III	40	16.3	59	31.9
IV	33	13.5	25	13.5
T classification
T₁	110	44.9	36	19.5
T₂	107	43.7	92	49.7
T₃	18	7.3	41	22.2
T₄	10	4.1	16	8.6
N classification
N₀	135	55.1	70	37.8
N₁	51	20.8	78	42.2
N₂	41	16.7	30	16.2
N₃	18	7.3	7	3.8
Distant metastasis
Yes	212	86.5	177	95.7
No	33	13.5	8	4.3
Estrogen receptor
Positive	174	71.0	101	54.6
Negative	71	29.0	84	45.4
Unknown	0		0
Progesterone receptor
Positive	146	66.3	110	59.5
Negative	74	33.7	75	40.5
Unkown	25		0
Her2
Positive	43	22.3	21	21.4
Negative	150	77.7	77	78.6
Unknown	52		87
MACC1 expression
High expression	136	55.5	111	60.0
Low expression	109	44.5	74	40.0
Endocrine therapy
tamoxifen	122	43.8
No treatment	95	56.2
Unknown	28

Back to article page

ISSN: 2045-3701

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com